tiprankstipranks
Trending News
More News >
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (HK:2315)
:2315
Hong Kong Market
Advertisement

Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (2315) Similar Stocks

Compare
1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
HK$22.64
HK$8.28B
226.00
255.42%
0 Buy
1 Hold
0 Sell
Hold
Ascletis Pharma, Inc.
HK$13.68
HK$14.01B
1631.65%
1 Buy
2 Hold
0 Sell
Moderate Buy
Lepu Biopharma Co. Ltd. Class H
HK$8.68
HK$15.87B
257.20%
0 Buy
1 Hold
0 Sell
Hold
Keymed Biosciences, Inc.
HK$69.15
HK$19.41B
107.97%
0 Buy
1 Hold
0 Sell
Hold
CARsgen Therapeutics Holdings Ltd.
HK$23.10
HK$12.93B
573.47%
0 Buy
0 Hold
1 Sell
Moderate Sell
Shandong Boan Biotechnology Company., Limited. Class H
HK$13.88
HK$8.41B
218.77
52.86%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
22.64
16.21
252.10%
HK:1672
Ascletis Pharma, Inc.
13.68
12.83
1509.41%
HK:2157
Lepu Biopharma Co. Ltd. Class H
8.68
6.12
239.06%
HK:2162
Keymed Biosciences, Inc.
69.15
33.90
96.17%
HK:2171
CARsgen Therapeutics Holdings Ltd.
23.10
19.85
610.77%
HK:6955
Shandong Boan Biotechnology Company., Limited. Class H
13.88
4.69
51.03%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis